These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31770534)

  • 1. Effect of polymyxin B hemoperfusion on the outcome of patients with sepsis and septic shock.
    Lin WT; Lai CC; Wang JJ; Chao CM
    J Infect; 2020 Mar; 80(3):350-371. PubMed ID: 31770534
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
    Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
    Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
    Dellinger RP; Bagshaw SM; Antonelli M; Foster DM; Klein DJ; Marshall JC; Palevsky PM; Weisberg LS; Schorr CA; Trzeciak S; Walker PM;
    JAMA; 2018 Oct; 320(14):1455-1463. PubMed ID: 30304428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T; Sugaya T; Koide H
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin B hemoperfusion in sepsis: growing body of evidence and occasional conflicting results.
    Antonelli M; Ronco C
    Blood Purif; 2015; 39(1-3):I-II. PubMed ID: 25998615
    [No Abstract]   [Full Text] [Related]  

  • 6. Polymyxin B hemoperfusion in septic shock: just look at the evidence!
    Antonelli M; Cutuli SL; Ronco C
    Intensive Care Med; 2015 Sep; 41(9):1731-2. PubMed ID: 26197847
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
    Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
    Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymyxin B hemoperfusion (PMX-F) for severe sepsis and septic shock].
    Hayashi Y
    Nihon Rinsho; 2012 Feb; 70(2):311-4. PubMed ID: 22413537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Description of the hemodynamic and respiratory effects of hemoperfusion treatment with polymyxin B in patients with abdominal septic shock].
    Navarro R; Guerrero M; González M; Quecedo L; García A; Ramasco F
    Rev Esp Anestesiol Reanim; 2013; 60(6):344-7. PubMed ID: 23276381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B haemoperfusion in septic shock patients.
    Shime N; MacLaren G
    Intensive Care Med; 2015 Nov; 41(11):2033. PubMed ID: 26179431
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin B hemoperfusion and mortality in abdominal septic shock.
    Amaral AC
    JAMA; 2009 Nov; 302(18):1968-9; author reply 1969-70. PubMed ID: 19903914
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymyxin B hemoperfusion and mortality in abdominal septic shock.
    Vincent JL
    JAMA; 2009 Nov; 302(18):1968; author reply 1969-70. PubMed ID: 19903915
    [No Abstract]   [Full Text] [Related]  

  • 15. Balancing the "humors" in severe sepsis: still a role for extracorporeal therapies?
    Darmon M; Bagshaw SM; Forni LG
    Intensive Care Med; 2015 Jun; 41(6):1132-4. PubMed ID: 25971380
    [No Abstract]   [Full Text] [Related]  

  • 16. Septic neonate rescued by polymyxin B hemoperfusion.
    Hirakawa E; Ibara S; Tokuhisa T; Hiwatashi S; Hayashida Y; Maede Y; Matsui T; Nakazawa Y; Inoue T; Kodaira Y
    Pediatr Int; 2013 Jun; 55(3):e70-2. PubMed ID: 23782384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience of direct hemoperfusion using polymyxin B-immobilized fiber on patients with endotoxin shock from urosepsis].
    Ushida H; Koizumi S; Johnin K; Katoh K; Okada Y
    Hinyokika Kiyo; 2001 May; 47(5):329-31. PubMed ID: 11433754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effects of use polymyxin B fixed on fibers in liver transplant patients with severe sepsis or septic shock.
    Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Perrella S; Cappannoli A; Mazzarino V; Tosi A; Novelli G; Rossi M; Ginanni Corradini S; Ferretti G; Berloco PB; Pietropaoli P
    Transplant Proc; 2007; 39(6):1953-5. PubMed ID: 17692664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B hemoperfusion and mortality in abdominal septic shock.
    Kida Y
    JAMA; 2009 Nov; 302(18):1969; author reply 1969-70. PubMed ID: 19903916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.